STAGE IIIA PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIIA PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-phase study tested a new drug (AZD8186) combined with chemotherapy (docetaxel) in 23 people with advanced solid tumors that have certain gene mutations (PTEN or PIK3CB). The main goal was to find the safest dose and understand side effects. The study is complete, and r…
Matched conditions: STAGE IIIA PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
New drug combo shows promise in High-Risk prostate cancer trial
Disease control CompletedThis study tested whether adding a drug called niraparib to standard radiation and hormone therapy can lower the chance of prostate cancer returning in men with high-risk disease. Twenty-two men participated. The approach aims to block cancer cells from repairing their DNA, causi…
Matched conditions: STAGE IIIA PROSTATE CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
Smart devices track cancer recovery at home
Knowledge-focused CompletedThis study tested whether using at-home monitoring devices (like a wristband pedometer, scale, and blood pressure cuff) can help improve care for cancer patients after they leave the hospital following surgery. 22 patients with various cancers participated. The goal was to see if…
Matched conditions: STAGE IIIA PROSTATE CANCER AJCC V8
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:50 UTC